Advanced search
Publication Cover
Journal of Inflammation Research Volume 15, 2022 - Issue
Submit an article Journal homepage
376
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma

Jin Wu1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Tianyi Zhang1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Haofeng Xiong1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China;4 Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Liujun Zeng1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Zijia Wang1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Ying Peng1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Weijun Chen1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
,
Xin Hu1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of China
&
Tong Su1 Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;2 Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, People’s Republic of China;3 Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, 410008, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-7466-3999
ORCID Icon show all
Pages 141-152 | Published online: 08 Jan 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Pei J, Liu J, Chen Y, Liu Y, Liao X, Pan J. Relationship between maxillary posterior molar roots and the maxillary sinus floor: cone-beam computed tomography analysis of a western Chinese population. J Int Med Res. 2020;48(6):300060520926896. doi:10.1177/0300060520926896
  • Arun I, Maity N, Hameed S, et al. Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma. Head Neck. 2021;43(2):520–533. doi:10.1002/hed.26715
  • Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc3245
  • Butterfield LH. Cancer vaccines. BMJ. 2015;350. doi:10.1136/bmj.h988.
  • Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348(6230):62–68. doi:10.1126/science.aaa4967
  • Zhang R, Zhang Z, Liu Z, et al. Adoptive cell transfer therapy for hepatocellular carcinoma. Front Med. 2019;13(1):3–11. doi:10.1007/s11684-019-0684-x
  • Kujan O, van Schaijik B, Farah CS. Immune checkpoint inhibitors in oral cavity squamous cell carcinoma and oral potentially malignant disorders: a systematic review. Cancers. 2020;12(7):1937. doi:10.3390/cancers12071937
  • Whiteside TL. Tumor-Infiltrating Lymphocytes in Human Malignancies. RG Landes Company; 1993.
  • Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821. doi:10.1038/s41423-020-0488-6
  • Chevrier S, Levine JH, Zanotelli VRT, et al. An immune atlas of clear cell renal cell carcinoma. Cell. 2017;169(4):736–749. doi:10.1016/j.cell.2017.04.016
  • Guo X, Zhang Y, Zheng L, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24(7):978–985. doi:10.1038/s41591-018-0045-3
  • Puram SV, Tirosh I, Parikh AS, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611–1624. doi:10.1016/j.cell.2017.10.044
  • Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer. 2017;117(4):451–460.
  • Zhou C, Wu Y, Jiang L, et al. Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma. J Oral Pathol Med. 2018;47(4):359–367. doi:10.1111/jop.12698
  • Fang J, Li X, Ma D, et al. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer. 2017;17(1):1–9. doi:10.1186/s12885-017-3317-2
  • Che Y, Luo Z, Zhang C, Sun N, Gao S, He J. Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma. Int Immunopharmacol. 2020;87:106802.
  • Zou C, Huang D, Wei H, et al. Identification of immune-related risk signatures for the prognostic prediction in oral squamous cell carcinoma. J Immunol Res. 2021;2021:6303759.
  • Song D, Tian J, Han X, Li X. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Eur Arch Oto-Rhino-Laryngol. 2021;1–11. doi:10.1007/s00405-020-06540-4
  • Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. doi:10.1186/s13059-017-1349-1
  • Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
  • Sei JJ, Cox KS, Dubey SA, et al. Effector and central memory poly-functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) vaccination. Front Immunol. 2015;6:553. doi:10.3389/fimmu.2015.00553
  • Hu X, Xia K, Xiong H, Su T. G3BP1 may serve as a potential biomarker of proliferation, apoptosis, and prognosis in oral squamous cell carcinoma. J Oral Pathol Med. 2021. doi:10.1111/jop.13199
  • Yang Z, Yan G, Zheng L, et al. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration. OncoImmunology. 2021;10(1):1938890. doi:10.1080/2162402x.2021.1938890
  • Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662–680. doi:10.1038/s41568-020-0285-7
  • Mackay CR. Dual personality of memory T cells. Nature. 1999;402(6763):3–4. doi:10.1038/35005503
  • Rahimi RA, Luster AD. Redefining memory T cell subsets. Trends Immunol. 2020;41(8):645–648. doi:10.1016/j.it.2020.06.003
  • Pepper M, Jenkins MK. Origins of CD4+ effector and central memory T cells. Nat Immunol. 2011;12(6):467–471. doi:10.1038/ni.2038
  • Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol. 2013;13(5):309–320. doi:10.1038/nri3442
  • Wakatsuki K, Sho M, Yamato I, et al. Clinical impact of tumor-infiltrating CD45RO+ memory T cells on human gastric cancer. Oncol Rep. 2013;29(5):1756–1762. doi:10.3892/or.2013.2302
  • Hotta K, Sho M, Fujimoto K, et al. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer. 2011;105(8):1191–1196. doi:10.1038/bjc.2011.368
  • Zhou C, Li J, Wu Y, Diao P, Yang J, Cheng J. High density of intratumor CD45RO+ memory tumor-infiltrating lymphocytes predicts favorable prognosis in patients with oral squamous cell carcinoma. J Oral Maxillofacial Surg. 2019;77(3):536–545. doi:10.1016/j.joms.2018.09.039
  • Vahidi Y, Faghih Z, Talei A-R, Doroudchi M, Ghaderi A. Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: a focus on T stem cell memory cells. Cell Oncol. 2018;41(1):1–11. doi:10.1007/s13402-017-0352-6
  • Takeuchi Y, Tanemura A, Tada Y, Katayama I, Kumanogoh A, Nishikawa H. Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma. Int Immunol. 2018;30(1):13–22. doi:10.1093/intimm/dxx073
  • Aghajani MJ, Cooper A, McGuire H, et al. Pembrolizumab for anaplastic thyroid cancer: a case study. Cancer Immunol Immunother. 2019;68(12):1921–1934. doi:10.1007/s00262-019-02416-7
  • Lee JJ, Chang YL, Lai WL, et al. Increased prevalence of interleukin‐17–producing CD4+ tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck. 2011;33(9):1301–1308. doi:10.1002/hed.21607
  • Lee M-H, Chang JT-C, Liao C-T, Chen Y-S, Kuo M-L, Shen C-R. Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. Oncotarget. 2018;9(11):9825. doi:10.18632/oncotarget.23934
  • Rabjerg M, Bjerregaard H, Halekoh U, Jensen BL, Walter S, Marcussen N. Molecular characterization of clear cell renal cell carcinoma identifies CSNK 2A1, SPP 1 and DEFB 1 as promising novel prognostic markers. Apmis. 2016;124(5):372–383. doi:10.1111/apm.12519
  • Álvarez ÁH, Velázquez MM, de Oca EPM. Human β-defensin 1 update: potential clinical applications of the restless warrior. Int J Biochem Cell Biol. 2018;104:133–137. doi:10.1016/j.biocel.2018.09.007
  • Ghosh SK, McCormick TS, Weinberg A. Human beta defensins and cancer: contradictions and common ground. Front Oncol. 2019;9:341. doi:10.3389/fonc.2019.00341
  • Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human β‐defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24(5):353–360. doi:10.1111/j.1399-302x.2009.00512.x
  • Han Q, Wang R, Sun C, et al. Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients. PLoS One. 2014;9(3):e91867. doi:10.1371/journal.pone.0091867
  • Subbiah HV, Babu PR, Subbiah U. In silico analysis of non-synonymous single nucleotide polymorphisms of human DEFB1 gene. Egypt J Med Human Genetics. 2020;21(1):1–9. doi:10.1186/s43042-020-00110-3
  • Yang D, Chertov O, Bykovskaia SN, et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286(5439):525–528. doi:10.1126/science.286.5439.525
  • Camus M, Galon J. Memory T-cell responses and survival in human cancer: remember to stay alive. Memory T Cells. 2010;166–177. doi:10.1007/978-1-4419-6451-9_13
  • Hu Z, Gu X, Zhong R, Zhong H. Tumor-infiltrating CD45RO+ memory cells correlate with favorable prognosis in patients with lung adenocarcinoma. J Thorac Dis. 2018;10(4):2089. doi:10.21037/jtd.2018.03.148

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.